Terns Pharmaceuticals
company
Funding Round
Post-IPO Equity
Money Raised
$ 86.30M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion |
|---|
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Aug 12, 2022 | Post-IPO Equity | $ 65M | Fairmount Funds Management,Venrock Healthcare Capital Partners | Detail |
| Oct 30, 2018 | Series B | $ 80M | Decheng Capital,Lilly Asia Ventures,etc. | Detail |
| Jan 5, 2021 | Series C | $ 87M | Deepfield,Eli Lilly,etc. | Detail |
| Apr 4, 2018 | Series A | $ 30M | Lilly Asia Ventures | Detail |
| Feb 4, 2021 | IPO | $ 127.50M | Detail |
